Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 1 day agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 15 hours agovaccine makers to focus on the latest versions of the virus, and not the JN.1 variant. A U.S. Food...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 1 day agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 2 hours agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 4 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
Thousands of Patients to Be Given World's First Cancer Vaccine
Futurism via Yahoo News· 6 days agoThe United Kingdom's National Health Service (NHS) is fast-tracking patients for its game-changing...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 7 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 7 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 7 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 6 days agoThe vaccine will be Moderna’s second product to enter the U.S. market after the FDA’s approval of...